Zuellig Pharma enters strategic partnership with Sanofi in Vietnam

16 September 2015

Hong Kong-headquartered health services provider Zuellig Pharma continues to strengthen its position as the leading healthcare services provider in Asia with the announcement of a new strategic partnership with French pharma major Sanofi (Euronext: SAN) in Vietnam, in cooperation with local partners Phytopharma and Sapharco.

The partnership with Sanofi marks the realization of the plan for an expanded cooperation between the largest health care manufacturer and the largest healthcare logistics service provider in Vietnam, reinforcing Zuellig Pharma’s strategic development as a complete healthcare solutions provider in key markets across the Asia Pacific region.

Sanofi has invested $75 million in third production facility

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK